Jasper Development Group LLC Secures Coveted Medical Marijuana Processor License in Alabama

JASPER, Ala., June 21, 2023 /PRNewswire/ — Catalyst Business Consulting (Catalyst BC) is thrilled to announce their client and partner, Jasper Development Group Inc. (JDG), has obtained a highly sought-after merit-based, limited license to process medical marijuana in Alabama from hundreds of applications. This monumental achievement marks a significant milestone for both Alabama locals, Jasper … Read more

Zymo Research donates $25,000 to support Center for Virus Research at the University of California, Irvine

IRVINE, Calif., June 21, 2023 /PRNewswire/ — Zymo Research, a leading innovation company for biomedical products and services has donated $25,000 to the Regents of the University of California to support the Center for Virus Research at the University of California, Irvine (UCI). “We are grateful for the generous support from Zymo Research,” said Dr. … Read more

HAND & STONE AMPS UP CRYOSKIN OFFERINGS INTRODUCING MORE REVOLUTIONARY BODY AND FACIAL CONTOURING TREATMENTS

– Leading spa franchise expands service to help customers achieve remarkable body and skin transformation – PHILADELPHIA, June 21, 2023 /PRNewswire/ — Hand & Stone Massage and Facial Spa, the nation’s leading luxury massage and facial spa franchise, has announced the expansion of its menu with the launch of Cryoskin, a non-invasive facial and body contouring … Read more

How to Grow After Trauma

Wounded Warrior Project® tips from veterans help normalize seeking care.   JACKSONVILLE, Fla., June 21, 2023 /PRNewswire/ — What does life look like with post-traumatic stress disorder (PTSD)? For Tonya Oxendine, who served three decades in the U.S. Army, life with PTSD is full of laughter and joy. That was not always the case. Experience the … Read more

Galderma lança aplicativo de realidade aumentada para simulação em tempo real de possíveis efeitos de tratamentos estéticos injetáveis

FACE by GaldermaTM está em sua primeira fase de lançamento e já traz dados surpreendentes: 72% dos pacientes que usaram a tecnologia agendaram um procedimento estético injetável após o uso do aplicativo SÃO PAULO, 21 de junho de 2023 /PRNewswire/ — A Galderma, especialista em soluções para cuidados com a pele, que abrange medicamentos de prescrição médica, dermocosméticos … Read more

Non-insulin Diabetes Therapeutics Market size is set to grow by USD 31,251.55 million from 2022-2027; Increasing number of people with Type 2 diabetes will boost the market- Technavio

NEW YORK, June 21, 2023 /PRNewswire/ — The global non-insulin diabetes therapeutics market size is estimated to grow by USD 31,251.55 million from 2022 to 2027. The market is estimated to grow at a CAGR of 10.82%. However, the growth momentum will progress during the forecast period. North America held the largest share of the global market in … Read more

INTERNATIONAL ISOTOPES INC. ANNOUNCES THE ACQUISITION OF THE AMICI INC. PRODUCT LINE

The Products Include All Molds, Manufacturing, And Registration Rights To AMICI’s Leading Products, Including The “Swirler”, “UltraShield”, and “Tru-Fit” Mouth Piece IDAHO FALLS, Idaho, June 21, 2023 /PRNewswire/ — International Isotopes Inc. (OTCQB: INIS) (“International Isotopes,” “INIS” or the “Company”) is pleased to announce that it has acquired the manufacturing molds, device registrations, trademarks, and all production … Read more

New research highlights a significant and continued gap in achieving diversity in clinical trials of medical therapies

Clario and Tufts Center for the Study of Drug Development (CSDD) to present new results at the DIA 2023 Annual Global Meeting showing a sustained under-representation of minority communities in pivotal trials supporting new drug and biologic approvals. Data from 1,165 pivotal trials for 550 NDAs and BLAs were collected (FDA approvals 2007 – 2021) … Read more

New research highlights a significant and continued gap in achieving diversity in clinical trials of medical therapies

Clario and Tufts Center for the Study of Drug Development (CSDD) to present new results at the DIA 2023 Annual Global Meeting showing a sustained under-representation of minority communities in pivotal trials supporting new drug and biologic approvals. Data from 1,165 pivotal trials for 550 NDAs and BLAs were collected (FDA approvals 2007 – 2021) … Read more

Canopy Growth to Report Fourth Quarter and Fiscal Year 2023 Financial Results on June 22, 2023

SMITHS FALLS, ON, June 21, 2023 /PRNewswire/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the fourth quarter and fiscal year 2023 ended March 31, 2023, and file the Company’s comprehensive annual report on Form 10-K for the fiscal years ended March 31, 2023 … Read more